Related Experiment Video
Updated: Jun 2, 2026

Quantification, Viability Assessment, and Visualization Strategies for Acinetobacter Biofilms
Published on: August 4, 2023
Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters
Nadia Kazemi Pour1, Devendra H Dusane, Prashant K Dhakephalkar
1Department of Microbiology, University of Pune, Pune, India.
Abstract:
Fifty Acinetobacter isolates were obtained from urinary tract infections and urinary catheter samples. Analytical profile index assays identified 47 isolates as Acinetobacter baumannii and three as Acinetobacter lwoffii. Six A. baumannii isolates (A1-A6) displayed hydrophobicity indices >70%. Twenty isolates exhibited lectin activity. Biofilm formation by these isolates was compared with those with low hydrophobicity index values (A45-A50). Biofilms on different surfaces were confirmed by light microscopy, epifluorescence microscopy and by obtaining scanning electron microscope images. Biofilm production was maximal at 30 °C, pH 7.0 in a medium with 5.0 g L(-1) NaCl, and its efficiency was reduced on urinary catheter surfaces at sub-minimum inhibitory concentration concentrations of colistin. Plasmid-mediated antibiotic resistance was observed in selected isolates of A. baumannii and experiments of conjugation and transformation showed the occurrence of gene transfer. Plasmid curing was used to examine the function of plasmids. Five plasmids of A. baumannii A3 were cured but no differences were observed between wild-type and plasmid-cured strains with respect to the biofilm formation capabilities. The prevalence of A. baumannii strains with biofilm mode of growth could explain their ability to persist in clinical environments and their role in device-related infections.
Insights
Acinetobacter baumannii, a common cause of urinary tract infections, forms robust biofilms on medical devices. This study reveals biofilm formation is influenced by environmental factors and not plasmid-cured in A. baumannii.
Area of Science:
- Microbiology
- Infectious Diseases
- Medical Devices
Background:
- Acinetobacter species, particularly Acinetobacter baumannii, are significant opportunistic pathogens.
- Urinary tract infections and catheter-associated infections are common clinical problems.
- Biofilm formation is a key virulence factor for Acinetobacter species in healthcare settings.
Purpose of the Study:
- To characterize Acinetobacter isolates from urinary samples.
- To investigate factors influencing biofilm formation in Acinetobacter baumannii.
- To explore the role of plasmids in antibiotic resistance and biofilm production.
Main Methods:
- Isolation and identification of Acinetobacter species using Analytical Profile Index.
- Assessment of bacterial hydrophobicity and lectin activity.
- Biofilm quantification and visualization using microscopy (light, epifluorescence, scanning electron).
- Optimization of biofilm formation conditions (temperature, pH, NaCl concentration).
- Investigation of colistin's effect on biofilm and plasmid-mediated antibiotic resistance via conjugation, transformation, and plasmid curing.
Main Results:
- 47 of 50 isolates were identified as Acinetobacter baumannii.
- Six A. baumannii isolates exhibited high hydrophobicity (>70%), and 20 showed lectin activity.
- Biofilm formation was optimal at 30°C, pH 7.0, and 5.0 g/L NaCl.
- Biofilm efficiency decreased on urinary catheter surfaces and with sub-minimum inhibitory concentrations of colistin.
- Plasmid-mediated antibiotic resistance was confirmed, but plasmid curing did not affect biofilm formation capabilities.
Conclusions:
- Acinetobacter baumannii strains possess significant biofilm-forming capabilities, contributing to persistence in clinical environments.
- Environmental conditions significantly impact biofilm production.
- While plasmids carry antibiotic resistance genes, they do not appear to be essential for biofilm formation in the studied A. baumannii isolates.
- The findings highlight the importance of understanding biofilm dynamics for managing device-related infections.
Related Concept Videos
Biofilms
Urinary Tract Infection II: Pathophysiology
